The endocannabinoid anandamide neither impairs in vitro T-cell function nor induces regulatory T-cell generation

Anticancer Research

Volumn 28, Issue 6 A, 2008, Pages 3743-3748

  Lissoni, Paolo ^a   Tintori, Andrea ^a   Fumagalli, Luca ^a   Brivio, Fernando ^a   Messina, Giuseppina ^a   Parolini, Daniela ^a   Biondi, Andrea ^a   Balestra, Anna ^a   D'Amico, Giovanna ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Anandamide; Anticancer immunity; Cannabinoids; Lymphocytes; Regulatory T cell

Indexed keywords

ANANDAMIDE; ENDOCANNABINOID; INTERLEUKIN 10; INTERLEUKIN 2;

ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IMMUNOSTIMULATION; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; NATURAL KILLER T CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ANTIGENS, CD3; ARACHIDONIC ACIDS; CANNABINOIDS; CYTOKINES; HUMANS; IMMUNOPHENOTYPING; K562 CELLS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; POLYUNSATURATED ALKAMIDES; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 58149173502     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Jankovic BD: Neuroimmunomodulation. Ann NY Acad Sci 741: 379-385, 1994.
2. Grotenhermen F: Pharmacology of cannabinoids. Neuroendocrinol Lett 25: 14-23, 2004.
3. Grossman A and Clement-Jones V: Opiate receptors, enkephalins and endorphins. Clin Endocrinol Metab 12: 31-56, 1983.
4. Hollister LE: Health aspects of cannabis. Pharmacol Rev 38: 1-20, 1986.
5. Morley JE, Kay N, Allin J, Moon T and Billington CJ: Endorphins, immune functions and cancer. Psychopharmacol Bull 21: 485-488, 1985.
6. Dewey WL: Cannabinoid pharmacology. Pharmacol Rev 38: 151-178, 1986.
7. Rassmunssen M, Zhy W, Tonnesen J, Cadet P, Tonnesen E and Stefano GB: Effects of morphine on tumor growth. Neuroendocrinol Lett 23: 193-198, 2002.
8. Lewis JW, Shavit Y, Terman GW, Nelson IR, Gale RP and Liebeskind JC: Apparent involvement of opioid peptides in stress-induced enhancement of tumor growth. Peptides 4: 635-638, 1983.
9. Sacerdote P and Panerai AE: Role of opioids in the modulation of TH1/TH2 responses. Neuroimmunomodulation 6: 422-423, 1999.
10. Bifulco M, Leazza C, Portella G, Vitale M, Orlando P, De Petrocellis L and Di Marzo V: Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth. FASEB J 15: 2745-2747, 2001.
11. Sarfaraz S, Afaq F, Adhami VM and Mukhtar H: Cannabinoid receptor as a novel target for the treatment of prostate cancer. Cancer Res 65: 1635-1641, 2005.
12. Blazquez C, Casanova ML, Planas A, Del Pulgar TG, Villanueva C, Fernandez-Acenero MJ, Argones J, Huffman JW, Jorcano JL and Guzman M: Inhibition of tumor angiogenesis by cannabinoids. FASEB J 17: 529-531, 2003.
13. Joseph J, Niggemann B, Zaenker KS and Entschladen F: Anandamide is an endogenous inhibitor for the migration of tumor cells and T-lymphocytes. Cancer Immunol Immunother 53: 723-728, 2004.
14. Guzman M: Cannabinoids: Potential anticancer agents. Nat Rev Cancer 3: 745-755, 2003.
15. Munro S, Thomas KL and Abu Shaar M: Molecular characterization of a peripheral receptor for cannabinoids. Nature (London) 365: 61-65, 1993.
16. Berdyshev EV: Cannabinoid receptors and the regulation of immune response. Chem Phys Lip 108: 169-190, 2000.
17. Pertwee RG: Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74: 129-180, 1997.
18. Parolaro D and Massi P: Marijuana, THC and immune system. Acta Phytother 1: 36-41, 2002.
19. Smith SR, Tarminelli C and Denhardt G: Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 endotoxemic mice. J Pharmacol Exp Ther 293: 136-150m, 2000.
20. Zhu LX, Sharma S, Stolina M, Gardner B, Roth MD, Tashkin DP and Dubinnet SM: Δ-9-Tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J Immunol 165: 373-380, 2000.
21. Correa F, Mestre L, Docagne F and Guaza C: Activation of cannabinoid CB2 receptor negatively regulates IL-12 p40 production in murine macropheges: role of IL-10 and ERK 1/2 kinase signalling. Br J Pharmacol 145: 441-448, 2005.
22. Moore KW, O' Garra A, De Waal-Malefyt R, Vieira P and Mosmann TR: Interleukin-10. Ann Rev Immunol 11: 165-172, 1993.
23. Schwaz H, Blando FJ and Lotz M: Anandamide, an endogenous cannabinoid receptor agonist, inhibits lymphocytes proliferation and induces apoptosis. J Neuroimmunol 55: 107-115, 1994.
24. Katona S, Kaminski E, Sanders H and Zajicek J: Cannabinoid influence on cytokine profile in multiple sclerosis. Ciln Exp Immunol 140: 580-585, 2005.
25. Klein TW, Newton C and Friedman H: Cannabinoid receptors and the cytokine network. Adv Exp Med Biol 437: 215-222, 1998.
26. + immunoregulatory T-cells suppress polyclonal T-cell activation in vitro by inhibiting interleukin-2 prodution. J Exp Med 188: 287-291, 1998.
27. + regulatory T-cells. Semin Immunol 26: 89-95, 2004.
28. Vulcano M, Albanesi C, Stoppacciaro A, Bagnati R, D'Amico G, Struyf S ,Transidico P, Bonecchi R, DelPrete A, Allavena P, Ruco LP, Chiabrando C, Girolomoni G, Mantovani A and Sozzoni S: Dendritic cells as a major source of macrophage-derived chemokine (MDC) in vitro and in vivo. Eur J Immunol 31: 812-822, 2001
29. Whittington R and Faulds D: Interleukin-2. Drugs 46: 446-483, 1993.
30. Lissoni P, Pittalis S, Brivio F, Tisi E, Rovelli F, Ardizzoia A, Barni S, Tancini G, Giudici G, Biondi A, Conti A and Maestroni G: In vitro modulatory effects of interleukin-3 on macrophage activation induced by interleukin-2. Cancer 71: 2076-2081, 1993.
31. Spencer S, Lancz G and Goodfellow D: Suppression of human macrophage function in vitro by Δ-9-tetrahydrocannabinol. J Leukoc Biol 50: 423-426, 1991.
32. Fearon DT and Locksley RM: The instructive role of innate immunity in the acquired immune response. Science 272: 50-53, 1996.
33. Simson L, Ellyard JI, Dent LA, Matthaei KI, Rothenberg ME, Foster PS, Smyth MJ and Parish CR: Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance. J Immunol 178: 4222-4229, 2007.
34. Rivoltini L, Viggiano V, Spinazze S, Santoro A, Colombo MP, Takatsu K and Parmiani G: In vitro anti-tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2. Role of interleukin 5. Int J Cancer 54: 8-15, 1993.
35. Aguado T, Carracedo A, Julien B, Velasco G, Milman G, Mechoulam R, Alvarez L, Guzman M and Galve-Roperh I: Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis. J Biol Chem 282: 6854-6862, 2007.